Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey
Journal of Gastroenterology · 2025-07 · 60 (7) · 866-876
DOI: 10.1007/s00535-025-02232-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 07.03.2025. Verfasst von Takao Miwa und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology/Internal Medicine, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan. miwa.takao.a6@f.…. Hauptthemen laut MEDLINE: Hepatic Encephalopathy, Liver Cirrhosis, Practice Patterns, Physicians'. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Gifu University.
Abstract (Originalsprache)
Background
Covert hepatic encephalopathy (CHE) leads to devastating outcomes in patients with cirrhosis. This study aims to elucidate the current management and future perspectives of CHE in Japan.
Methods
A questionnaire-based cross-sectional study was conducted among physicians involved in managing cirrhosis in Japan. The primary aim was to elucidate the real-world management of CHE, including testing and treatment. Factors influencing the implementation of CHE testing were analyzed using a logistic regression model. Limitations and future perspectives for improving the management of CHE were also evaluated.
Results
Of 511 physicians surveyed, 93.9% recognized CHE as a significant problem, and 86.9% agreed that it should be tested. Overall, 62.8% of physicians tested for CHE, whereas 37.2% did not. Multivariable analysis identified institutional factors and certifying board as significant determinants of CHE test implementation. The Stroop (68.2%) and neuropsychiatric tests (57.5%) were the most commonly used methods of identifying CHE. Among those who tested for CHE, 87.7% treated CHE; the most common treatments were lactulose (81.5%), rifaximin (76.3%), and branched-chain amino acids (70.4%). Among non-testers, the primary barrier was the time requirement for testing. Proposals to encourage CHE testing included the development of simple tests and integration of multidisciplinary teams.
Conclusions
Most physicians involved in cirrhosis care in Japan recognize CHE as a significant problem that warrants testing. However, testing for CHE remains limited by institutional factors and physician specialties. Time requirements for CHE testing are the primary barrier, and simple tests and multidisciplinary teams are recommended to enhance CHE management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology/Internal Medicine, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan. miwa.takao.a6@f.gifu-u.ac.jp.
- Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, 980-8574, Japan.
- Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, 3-20-1 Chuo, Ami-Machi, Inashiki-Gun, Ibaraki, 300-3095, Japan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, Iwate Medical University School of Medicine, Nishitokuta 2-1-1, Yahaba-Cho, Shiwa-Gun, Yahaba, Iwate, 028-3694, Jap…
- Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto University, 1-1-1, Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan.
- Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-Ku, Osaka, 545-8585, Japan.
ORCID-Profile: Takao Miwa
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Gifu University
Zitieren
APA
Miwa, T., Tsuruoka, M., Ueda, H., Abe, T., Inada, H., Yukawa-Muto, Y., Ohara, M., Arai, T., Tamai, Y., Isoda, H., Tadokoro, T., Hanai, T., Ito, T., Tamaki, N., Sakamaki, A., Aoki, Y., Tada, F., Yoshio, S., Takahashi, H., …, & Shimizu, M. (2025). Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey. Journal of Gastroenterology, 60(7), 866-876. https://doi.org/10.1007/s00535-025-02232-0
Vancouver
Miwa T, Tsuruoka M, Ueda H, Abe T, Inada H, Yukawa-Muto Y, et al. Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey. Journal of Gastroenterology. 2025;60(7):866-876. doi:10.1007/s00535-025-02232-0
BibTeX
@article{Miwa2025,
author = {Miwa, Takao and Tsuruoka, Mio and Ueda, Hajime and Abe, Tamami and Inada, Hiroki and Yukawa-Muto, Yoshimi and Ohara, Masatsugu and Arai, Taeang and Tamai, Yasuyuki and Isoda, Hiroshi and Tadokoro, Tomoko and Hanai, Tatsunori and Ito, Takanori and Tamaki, Nobuharu and Sakamaki, Akira and Aoki, Yoshihiko and Tada, Fujimasa and Yoshio, Sachiyo and Takahashi, Hirokazu and Morishita, Asahiro and Ishikawa, Tsuyoshi and Inoue, Jun and Suda, Goki and Ogawa, Chikara and Atsukawa, Masanori and Hiraoka, Atsushi and Kuroda, Hidekatsu and Namisaki, Tadashi and Honda, Takashi and Kawaguchi, Takumi and Tanaka, Yasuhito and Terai, Shuji and Ikegami, Tadashi and Yoshiji, Hitoshi and Iwasa, Motoh and Shimizu, Masahito},
title = {Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey},
journal = {Journal of Gastroenterology},
year = {2025},
volume = {60},
number = {7},
pages = {866--876},
doi = {10.1007/s00535-025-02232-0}
}
EUVIMED